Detalhe da pesquisa
1.
Community-acquired Invasive Bacterial Disease in Urban Gambia, 2005-2015: A Hospital-based Surveillance.
Clin Infect Dis
; 69(Suppl 2): S105-S113, 2019 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31505627
2.
The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen.
Vaccines (Basel)
; 11(8)2023 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37631885
3.
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.
Lancet Infect Dis
; 23(3): 352-360, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273490
4.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Lancet Glob Health
; 11(11): e1743-e1752, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858585
5.
Prevalence of Panton-Valentine Leukocidin (PVL) and Antimicrobial Resistance in Community-Acquired Clinical Staphylococcus aureus in an Urban Gambian Hospital: A 11-Year Period Retrospective Pilot Study.
Front Cell Infect Microbiol
; 9: 170, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31192162
6.
Patients' Satisfaction With Care From Nigerian Federal Capital Territory's Public Secondary Hospitals: A Cross-Sectional Study.
J Patient Exp
; 5(4): 250-257, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30574544